Hofseth Biocare ASA operates within the Medicinals and botanicals sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Hofseth Biocare ASA with three other
pharmaceutical manufacturers in Europe:
sales of 723.50 million Russian Rubles [US$10.84 million]
Venture Life Group plc
of the United Kingdom
(£16.05 million [US$20.14 million]
based in the United Kingdom
(£10.88 million [US$13.65 million]
of which 100%
was Medical and Scientific Research).
Sales increased substantially in 2017:
During the year ended December of 2017, sales at
Hofseth Biocare ASA were NOK 118.48 million (US$13.73 million).
increase of 486.4%
versus 2016, when the company's sales were NOK 20.20 million.